Aspreva Pharmaceuticals Corporation

67 articles about Aspreva Pharmaceuticals Corporation

• Lupus Nephritis Therapies Battle to a Draw, Aspreva Pharmaceuticals Corporation Study

  4/16/2009

• Aspreva Pharmaceuticals Corporation Plan of Arrangement with Galenica Completed

  1/4/2008

• Aspreva Pharmaceuticals Corporation Receives Investment Canada Approval for Acquisition by Galenica Pharmaceuticals

  12/26/2007

• Aspreva Pharmaceuticals Corporation Receives Final Court Approval for Acquisition by Galenica Pharmaceuticals

  12/19/2007

• Aspreva Pharmaceuticals Corporation Obtains Shareholder Approval for Acquisition by Galenica Pharmaceuticals

  12/18/2007

• Aspreva Pharmaceuticals Corporation Sends Materials for Special Meeting to be Held December 17 Shareholders and Optionholders to Vote on Proposed Plan of Arrangement with Galenica

  11/26/2007

• Aspreva Pharmaceuticals Corporation Sends Materials for Special Meeting to be Held December 17

  11/26/2007

• Aspreva Pharmaceuticals Corporation to be Acquired by Galenica For $915 Million

  10/18/2007

• Aspreva Pharmaceuticals Corporation Announces Preliminary Revenues for Third Quarter 2007

  10/17/2007

• Aspreva Pharmaceuticals Corporation to Announce 2007 Third Quarter Results on October 31st

  10/16/2007

• Aspreva Pharmaceuticals Corporation Halts CellCept Filing

  9/10/2007

• Aspreva Pharmaceuticals Corporation Pays Roche for CellCept Development in China

  8/29/2007

• Aspreva Pharmaceuticals Corporation Announces Results for Second Quarter 2007

  8/1/2007

• Aspreva Pharmaceuticals Corporation Announces Preliminary Revenues for Second Quarter 2007

  7/16/2007

• Aspreva Pharmaceuticals Corporation to Present at the Sixth Annual Needham Biotechnology and Medical Technology Conference in New York

  6/7/2007

• Aspreva Pharmaceuticals Corporation Says FDA Fast-Tracks CellCept Lupus Drug

  6/7/2007

• Aspreva Pharmaceuticals Corporation to Present at the Bank of America 2007 Health Care Conference in Las Vegas

  5/24/2007

• Aspreva Pharmaceuticals Corporation Completes Expanded Patient Enrollment in Phase III Clinical Trialfor CellCept in Pemphigus Vulgaris

  5/23/2007

• Four Cheap Biotech Stock Picks: Amgen(Jobs), Aspreva Pharmaceuticals Corporation, Exelixis, Inc.(Jobs), PDL BioPharma, Inc.(Jobs)

  5/17/2007

• Aspreva Pharmaceuticals Corporation Reports Results for First Quarter 2007 and Announces Leadership Transition of Founding CEO Richard Glickman

  5/3/2007